Nilda Mesa's most recent trade in United Therapeutics Corp was a trade of 1,830 Stock Options done . Disclosure was reported to the exchange on July 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Nilda Mesa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 1,830 | 1,830 | - | - | Stock Options | |
| United Therapeutics Corp | Nilda Mesa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 650 | 650 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2025 | 590 | 5,473 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2025 | 590 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Nilda Mesa | Director | Sale of securities on an exchange or to another person at price $ 289.99 per share. | 24 Jun 2025 | 645 | 4,883 (0%) | 0% | 290.0 | 187,045 | Common Stock |
| United Therapeutics Corp | Nilda Mesa | Director | Sale of securities on an exchange or to another person at price $ 355.76 per share. | 30 Dec 2024 | 255 | 5,528 (0%) | 0% | 355.8 | 90,720 | Common Stock |
| United Therapeutics Corp | Nilda Mesa | Director | Sale of securities on an exchange or to another person at price $ 412.28 per share. | 08 Nov 2024 | 224 | 5,783 (0%) | 0% | 412.3 | 92,350 | Common Stock |
| United Therapeutics Corp | Nilda Mesa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 1,440 | 1,440 | - | - | Stock Options | |
| United Therapeutics Corp | Nilda Mesa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 590 | 590 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2024 | 900 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2024 | 900 | 6,007 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Nilda Mesa | Director | Sale of securities on an exchange or to another person at price $ 318.58 per share. | 25 Jun 2024 | 266 | 5,107 (0%) | 0% | 318.6 | 84,742 | Common Stock |
| United Therapeutics Corp | Nilda Mesa | Director | Sale of securities on an exchange or to another person at price $ 237.80 per share. | 27 Mar 2024 | 325 | 5,373 (0%) | 0% | 237.8 | 77,285 | Common Stock |
| United Therapeutics Corp | Nilda Mesa | Director | Sale of securities on an exchange or to another person at price $ 244.90 per share. | 19 Dec 2023 | 605 | 5,698 (0%) | 0% | 244.9 | 148,165 | Common Stock |
| United Therapeutics Corp | Nilda Mesa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 2,280 | 2,280 | - | - | Stock Options | |
| United Therapeutics Corp | Nilda Mesa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 900 | 900 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 880 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 880 | 6,686 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Nilda Mesa | Director | Sale of securities on an exchange or to another person at price $ 214.80 per share. | 05 May 2023 | 374 | 5,806 (0%) | 0% | 214.8 | 80,337 | Common Stock |
| United Therapeutics Corp | Nilda Mesa | Director | Sale of securities on an exchange or to another person at price $ 268.57 per share. | 07 Nov 2022 | 290 | 6,180 (0%) | 0% | 268.6 | 77,886 | Common Stock |
| United Therapeutics Corp | Nilda Mesa | Director | Sale of securities on an exchange or to another person at price $ 211.05 per share. | 28 Sep 2022 | 850 | 6,870 (0%) | 0% | 211.0 | 179,391 | Common Stock |
| United Therapeutics Corp | Nilda Mesa | Director | Sale of securities on an exchange or to another person at price $ 207.36 per share. | 28 Sep 2022 | 400 | 6,470 (0%) | 0% | 207.4 | 82,943 | Common Stock |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2022 | 1,080 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2022 | 1,080 | 7,720 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Nilda Mesa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 3,230 | 3,230 | - | - | Stock Options | |
| United Therapeutics Corp | Nilda Mesa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 1,080 | 1,080 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2021 | 1,680 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2021 | 1,680 | 1,680 (0%) | 0% | 0 | Common Stock |